Skip to main content
OpenTrials

Clinical trial condition

Ophthalmoplegia

Explore clinical trials studying Ophthalmoplegia. Study availability and eligibility vary by location and protocol.

140 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Ophthalmoplegia trial results

Completed

Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease

NCT02023866

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +40 more
Locations
  • University of California at San Diego (UCSD) San Diego, California, United States
  • Stanford University Stanford, California, United States
  • Akron Children's Hospital Akron, Ohio, United States
  • Baylor College of Medicine Houston, Texas, United States
View Trial Details
Completed

ADDIA Proof-of-Performance Clinical Study

NCT03030586

Conditions
Alzheimer Disease, Alzheimer Disease (AD), Basal Ganglia Diseases, +31 more
Locations
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • ERASME Hospital Brussels, Belgium
  • Hopitaux Universitaires de Strasbourg Strasbourg, Alsace, France
  • Centre Hospitalier Universitaire de Besançon Besançon, France
View all 13 locations
View Trial Details
Completed

A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration

NCT00703677

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +21 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Louisville Louisville, Kentucky, United States
  • University of Maryland Baltimore, Maryland, United States
View Trial Details
Completed

The KHENEREXT Study

NCT04604548

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +35 more
Locations
  • Rigshospitalet, University of Copenhagen Copenhagen, Denmark
  • Klinikum der Universität München Friedrich-Baur-Institut München, Germany
  • Radboud University Medical Center Nijmegen, Netherlands
  • Institute for Ageing and Health Newcastle University Newcastle upon Tyne, United Kingdom
View Trial Details

Related conditions